GL261-luc: A Model for Immunotherapy and Radiation Therapy

Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer. GBM tumors grow within a fairly immunosuppressive tumor microenvironment and a relatively immune-privileged central nervous system. For patients diagnosed with GBM, prognosis remains poor with conventional therapies that include radiotherapy, chemotherapy, and surgery. Immunotherapy drugs provide an alternate approach to treatment, aiming to bolster … Continue reading GL261-luc: A Model for Immunotherapy and Radiation Therapy